Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piera Navarria

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
International Journal of Radiation Oncology, Biology, Physics|August 31, 2010
Clinical outcome of hypofractionated stereotactic radiotherapy for abdominal lymph node metastasesMario Bignardi, Piera Navarria, Pietro Mancosu, et al.
Radiation Oncology (London, England)|July 11, 2013
Dosimetric impact of inter-observer variability for 3D conformal radiotherapy and volumetric modulated arc therapy: the rectal tumor target definition caseFrancesca Lobefalo, Mario Bignardi, Giacomo Reggiori, et al.
Journal of Cancer Research and Clinical Oncology|June 8, 2014
Stereotactic body radiotherapy with flattening filter-free beams for prostate cancer: assessment of patient-reported quality of lifeMarta Scorsetti, Filippo Alongi, Elena Clerici, et al.
Medical Physics|February 11, 2012
Can volumetric modulated arc therapy with flattening filter free beams play a role in stereotactic body radiotherapy for liver lesions? A volume-based analysisGiacomo Reggiori, Pietro Mancosu, Simona Castiglioni, et al.
Lung Cancer (Amsterdam, Netherlands)|April 1, 2014
Stereotactic Ablative Radiotherapy for stage I histologically proven non-small cell lung cancer: an Italian multicenter observational studyUmberto Ricardi, Giovanni Frezza, Andrea Riccardo Filippi, et al.
Anticancer Research|October 23, 2009
Hypofractionated stereotactic radiotherapy and radiosurgery for the treatment of patients with radioresistant brain metastasesMarta Scorsetti, Angelica Facoetti, Piera Navarria, et al.
Journal of Cancer Research and Clinical Oncology|June 18, 2014
Outcome and toxicity profiles in the treatment of locally advanced lung cancer with volumetric modulated arc therapyMarta Scorsetti, Piera Navarria, Fiorenza De Rose, et al.
Radiation Oncology (London, England)|September 19, 2016
Phase II trial of hypofractionated VMAT-based treatment for early stage breast cancer: 2-year toxicity and clinical resultsFiorenza De Rose, Antonella Fogliata, Davide Franceschini, et al.
International Journal of Radiation Oncology, Biology, Physics|April 13, 2010
Volumetric modulation arc radiotherapy compared with static gantry intensity-modulated radiotherapy for malignant pleural mesothelioma tumor: a feasibility studyMarta Scorsetti, Mario Bignardi, Alessandro Clivio, et al.
Radiation Oncology (London, England)|February 3, 2012
Stereotactic body radiation therapy for liver tumours using flattening filter free beam: dosimetric and technical considerationsPietro Mancosu, Simona Castiglioni, Giacomo Reggiori, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
International Journal of Radiation Oncology, Biology, Physics|August 31, 2010
Clinical outcome of hypofractionated stereotactic radiotherapy for abdominal lymph node metastasesMario Bignardi, Piera Navarria, Pietro Mancosu, et al.
Radiation Oncology (London, England)|July 11, 2013
Dosimetric impact of inter-observer variability for 3D conformal radiotherapy and volumetric modulated arc therapy: the rectal tumor target definition caseFrancesca Lobefalo, Mario Bignardi, Giacomo Reggiori, et al.
Journal of Cancer Research and Clinical Oncology|June 8, 2014
Stereotactic body radiotherapy with flattening filter-free beams for prostate cancer: assessment of patient-reported quality of lifeMarta Scorsetti, Filippo Alongi, Elena Clerici, et al.
Medical Physics|February 11, 2012
Can volumetric modulated arc therapy with flattening filter free beams play a role in stereotactic body radiotherapy for liver lesions? A volume-based analysisGiacomo Reggiori, Pietro Mancosu, Simona Castiglioni, et al.
Lung Cancer (Amsterdam, Netherlands)|April 1, 2014
Stereotactic Ablative Radiotherapy for stage I histologically proven non-small cell lung cancer: an Italian multicenter observational studyUmberto Ricardi, Giovanni Frezza, Andrea Riccardo Filippi, et al.
Anticancer Research|October 23, 2009
Hypofractionated stereotactic radiotherapy and radiosurgery for the treatment of patients with radioresistant brain metastasesMarta Scorsetti, Angelica Facoetti, Piera Navarria, et al.
Journal of Cancer Research and Clinical Oncology|June 18, 2014
Outcome and toxicity profiles in the treatment of locally advanced lung cancer with volumetric modulated arc therapyMarta Scorsetti, Piera Navarria, Fiorenza De Rose, et al.
Radiation Oncology (London, England)|September 19, 2016
Phase II trial of hypofractionated VMAT-based treatment for early stage breast cancer: 2-year toxicity and clinical resultsFiorenza De Rose, Antonella Fogliata, Davide Franceschini, et al.
International Journal of Radiation Oncology, Biology, Physics|April 13, 2010
Volumetric modulation arc radiotherapy compared with static gantry intensity-modulated radiotherapy for malignant pleural mesothelioma tumor: a feasibility studyMarta Scorsetti, Mario Bignardi, Alessandro Clivio, et al.
Radiation Oncology (London, England)|February 3, 2012
Stereotactic body radiation therapy for liver tumours using flattening filter free beam: dosimetric and technical considerationsPietro Mancosu, Simona Castiglioni, Giacomo Reggiori, et al.
Pageof 5